These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34808497)

  • 1. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
    Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
    Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
    Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
    Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability.
    Zeng X; Lei Y; Pan S; Sun J; He H; Xiao D; Jamal M; Shen H; Zhou F; Shao L; Zhang Q
    J Leukoc Biol; 2023 Feb; 113(2):203-215. PubMed ID: 36822174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
    Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
    DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
    Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
    J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
    Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
    Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR9 and CCL25: A review of their roles in tumor promotion.
    Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
    J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.
    Zhang L; Xiao R; Xiong J; Leng J; Ehtisham A; Hu Y; Ding Q; Xu H; Liu S; Wang J; Tang DG; Zhang Q
    PLoS One; 2013; 8(1):e52384. PubMed ID: 23326330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
    Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
    Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin.
    Hu Y; Zhang L; Wu R; Han R; Jia Y; Jiang Z; Cheng M; Gan J; Tao X; Zhang Q
    Leuk Res; 2011 Sep; 35(9):1254-60. PubMed ID: 21295855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
    Yokoyama W; Kohsaka H; Kaneko K; Walters M; Takayasu A; Fukuda S; Miyabe C; Miyabe Y; Love PE; Nakamoto N; Kanai T; Watanabe-Imai K; Charvat TT; Penfold ME; Jaen J; Schall TJ; Harigai M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2014 Sep; 16(5):445. PubMed ID: 25248373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
    Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
    Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
    Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
    PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
    Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
    J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma
    Chai S; Wen Z; Zhang R; Bai Y; Liu J; Li J; Kongling W; Chen W; Wang F; Gao L
    PeerJ; 2022; 10():e13844. PubMed ID: 36003306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
    Johnson-Holiday C; Singh R; Johnson EL; Grizzle WE; Lillard JW; Singh S
    World J Surg Oncol; 2011 May; 9():46. PubMed ID: 21539750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.
    Schmutz C; Cartwright A; Williams H; Haworth O; Williams JH; Filer A; Salmon M; Buckley CD; Middleton J
    Arthritis Res Ther; 2010; 12(4):R161. PubMed ID: 20738854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.